Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05443607 · ClinicalTrials.gov registry record
Transplacental Transmission of RSV (TTRSV)
A clinical trial of Asthma and SARS CoV 2 Infection, sponsored by Tulane University.
- Active
- Registry status
- 300
- Enrollment target
- 2
- Study locations
NCT05443607: Active study of Asthma and SARS CoV 2 Infection, sponsored by Tulane University.
NCT05443607 is a study of Asthma and SARS CoV 2 Infection that is active but no longer recruiting, run by Tulane University. The registered enrollment target is 300 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05443607, a study of Asthma and SARS CoV 2 Infection, is active but no longer recruiting, sponsored by Tulane University.
- ACTIVE NOT RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
Aim 1: To study transplacental transmission of Respiratory Syncytial Virus (RSV) and how this is moderated by other maternal infections during pregnancy Aim 2: To test maternal blood for presence of RSV-specific immunoglobulins and how this is moderated by other maternal infections during pregnancy Aim 3: To test cord blood (fetal blood) for presence of RSV-specific immunoglobulins and other common viral pathogens Aim 4: To perform further tests (Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Droplet Digital Polymerase Chain Reaction (ddPCR) and immunoprobing) to confirm the presence of RSV and other common viral pathogens Aim 5: To follow these newborn infants up to 4 years of age to look for redisposition to respiratory diseases and growth parameters
Primary Outcome
The investigators will monitor the offspring via electronic medical records and mailed questioners to record respiratory symptoms such as upper respiratory infections, cough, wheezing.
Conditions Studied
Study Locations (2)
Louisiana
- Tulane University Lakeside Hospital - Metairie
- Ochsner Baptist Hospital - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-05-25 |
| Est. Completion | 2028-08 |
What the registry record for NCT05443607 still lists
NCT05443607 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (81% lower).
The record links to 4 conditions, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT05443607 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT05443607 about?
NCT05443607 is a clinical study titled "Transplacental Transmission of RSV (TTRSV)". Aim 1: To study transplacental transmission of Respiratory Syncytial Virus (RSV) and how this is moderated by other maternal infections during pregnancy Aim 2: To test maternal blood for presence of RSV-specific immunoglobulins and how this is moderated by other maternal infections during pregnancy...
What is the current status of trial NCT05443607?
This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2020-05-25. Estimated completion is 2028-08.
What conditions does trial NCT05443607 study?
This clinical trial studies the following conditions: Asthma, SARS CoV 2 Infection, Bronchiolitis, Respiratory Syncytial Virus (RSV).
Who is sponsoring clinical trial NCT05443607?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05443607 being conducted?
This trial has 2 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05443607's enrollment target sits among peer trials
300 125th of 374 higher than 247 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI